DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Aghajanian C, Blank SV, Goff BA. et al.
OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
J Clin Oncol 2012;
30: 2039-2045
Access:
We do not assume any responsibility for the contents of the web pages of other providers.